Atomo Diagnostics (ASX:AT1) advanced the Australia-wide rollout of its HIV self-test kit supported by both federal and state governments, according to a Wednesday filing with the Australian bourse.
The diagnostic firm expects to record over AU$1.3 million in revenue over two years from the scale-up of the national HIV self-test mail-out program operated by the National Association of People with HIV Australia with funding commitment from the federal government, the filing said.
Further, Atomo will expand its test-kit vending machine currently under a pilot program in South Australia to 70 machines nationwide from the current six machines in partnership with Thorne Harbour Health, the filing added.
As per the filing, the company also signed a deal to provide the tests to support NSW Healthâs MyTest pilot project via vending machines.
Shares of Atomo Diagnostic rose 4% in recent trade.
Price (AUD): $0.03, Change: $, Percent Change: +3.57%
Comments